Recent News

• 09.16.2025 - Verona Pharma to Present Additional Analyses of the Phase 3 ENHANCE Studies in COPD at ERS International Congress 2025
• 09.16.2025 - Verona Pharma to Present Additional Analyses of the Phase 3 ENHANCE Studies in COPD at ERS International Congress 2025

Recent Filings

• 09.11.2025 - DFAN14A Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
• 09.10.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 09.09.2025 - 8-K Current report
• 09.09.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 09.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.18.2025 - DEFM14A Definitive proxy statement relating to merger or acquisition
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors